中文

福瑞医科 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-28
ItemAmountY/Y
Revenue¥0.36B+9.0%
Gross profit¥0.27B
Operating income¥0.08B
Net income¥0.05B+25.1%
Gross margin74.9%Net margin 14.5%
Revenue Q/Q-27.1%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.09B25.1%
R&D¥0.03B8.8%
SG&A¥0.16B45.2%
Tax & other¥0.03B7.5%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

世纪鼎利琏升科技中青宝航宇微鼎龙股份万邦达中创环保万顺新材蓝色光标旗天科技中能电气天龙集团

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies